Good Therapeutics
Develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 Valuation: €0.0 | round | |
* | $250m | Acquisition | |
| Total Funding | 000k | ||
Digitalis Ventures(exited)
RiverVest Venture Partners(exited)
Roche Venture Fund(exited)
3×5 Partners(exited)
Codon Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
